- Home
- LUCD vs XTNT Comparison
LUCD vs XTNT Comparison
Compare LUCD & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUCD
- XTNT
- Stock Information
- Founded
- LUCD 2018
- XTNT N/A
- Country
- LUCD United States
- XTNT United States
- Employees
- LUCD N/A
- XTNT N/A
- Industry
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LUCD Health Care
- XTNT Health Care
- Exchange
- LUCD Nasdaq
- XTNT Nasdaq
- Market Cap
- LUCD 108.0M
- XTNT 89.8M
- IPO Year
- LUCD 2021
- XTNT N/A
- Fundamental
- Price
- LUCD $1.04
- XTNT $0.67
- Analyst Decision
- LUCD Strong Buy
- XTNT
- Analyst Count
- LUCD 5
- XTNT 0
- Target Price
- LUCD $3.70
- XTNT N/A
- AVG Volume (30 Days)
- LUCD 1.5M
- XTNT 104.0K
- Earning Date
- LUCD 11-12-2025
- XTNT 11-11-2025
- Dividend Yield
- LUCD N/A
- XTNT N/A
- EPS Growth
- LUCD N/A
- XTNT N/A
- EPS
- LUCD N/A
- XTNT N/A
- Revenue
- LUCD $4,360,000.00
- XTNT $127,766,000.00
- Revenue This Year
- LUCD $13.90
- XTNT $13.03
- Revenue Next Year
- LUCD $163.88
- XTNT N/A
- P/E Ratio
- LUCD N/A
- XTNT N/A
- Revenue Growth
- LUCD 14.74
- XTNT 15.16
- 52 Week Low
- LUCD $0.75
- XTNT $0.33
- 52 Week High
- LUCD $1.80
- XTNT $0.78
- Technical
- Relative Strength Index (RSI)
- LUCD 43.56
- XTNT 67.42
- Support Level
- LUCD $1.00
- XTNT $0.62
- Resistance Level
- LUCD $1.06
- XTNT $0.67
- Average True Range (ATR)
- LUCD 0.04
- XTNT 0.04
- MACD
- LUCD -0.00
- XTNT 0.00
- Stochastic Oscillator
- LUCD 28.57
- XTNT 93.33
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.